MaverickNY

Location: Earth
Website: http://icar.us/edKLEL

Joined Sep 18, 2009

Bio: Scientist, Icarus Consultants, Pharma, Biotech, Marketing Strategy, Science, Oncology, Hematology, Cancer, Leukemia, Lymphoma. Biotech investor

MaverickNY
RT @adamfeuerstein: $CELG -- Beat and Raise. Nice quarter --> http://bit.ly/oZwIFF

Jul. 28 at 8:16 AM

from Twitter
MaverickNY
RT @adamfeuerstein: My $HGSI story on the first sales report for Benlysta http://bit.ly/rf49il

Jul. 21 at 8:41 PM

from Twitter
MaverickNY
No surprise there RT @adamfeuerstein: RT @RPMReportMike: #dapa Vote on approval is: 6-9 AGAINST approval. $BMY

Jul. 19 at 4:33 PM

from Twitter
MaverickNY
@nexparadigm @matthewherper @adamfeuerstein completely agree with @chasingthealpha $MRK have been slow with rida.

Jul. 5 at 5:38 PM

from Twitter
MaverickNY
Dear $MSFT do you really need 500MB for an update to your crappy bloatware? sigh

Jun. 27 at 4:14 PM

from Twitter
MaverickNY
@adamfeuerstein that's about the same as the $CRIS data presented at AACR from memory

Jun. 20 at 5:46 AM

from Twitter
MaverickNY
Ooh $SGEN get an ODAC on July 14th for brentuximab/Adcetris in Hodgkin Lymphoma and ALCL... hold onto your hats! http://bit.ly/lM7Myv

Jun. 16 at 9:09 AM

from Twitter
MaverickNY
Ooh $SGEN get an ODAC on July 14th for brentuximab/Adcetris in Hodgkin Lymphoma and ALCL... hold onto your hats!

Jun. 16 at 9:08 AM

from Twitter
MaverickNY
My take on the recent European Hematology Association meeting: http://icar.us/ioEpxR $SGEN $NVS

Jun. 15 at 8:41 AM

from Twitter
MaverickNY
My take on the vemurafenib-ipilimumab combo: BMS and Roche join forces in metastatic melanoma http://bit.ly/iQ8pmG #ASCO11 $BMY $RHHBY

Jun. 2 at 9:24 AM

from Twitter
MaverickNY
RT @adamfeuerstein: My updated 2011 FDA Drug Approval Calendar --> http://bit.ly/lOzMSR $$

May. 25 at 8:07 AM

from Twitter
MaverickNY
Good news for $PFE's crizotinib as $ABT submits the diagnostic FISH test for the ALK mutation http://bit.ly/inVbig

May. 23 at 4:43 PM

from Twitter
MaverickNY
So $PFE's Sutent gets US approval for Sutent in NET and $AMGN's Dmab gets +ve CHMP opinion for Dmab in bone mets? Busy Friday!

May. 20 at 4:26 PM

from Twitter
MaverickNY
@adamfeuerstein the $DNDN booth at AUA was their biggest that I've seen yet but not many people in it whenever I went past

May. 19 at 2:47 PM

from Twitter
MaverickNY
Managing bone metastases with denosumab in prostate cancer: an interview with Dr Neal Shore http://bit.ly/jF7tsv $AMGN

May. 19 at 9:30 AM

from Twitter
MaverickNY
My take on the Dmab 147 data: http://bit.ly/mStovF #aua2011 $AMGN

May. 17 at 12:20 PM

from Twitter

Follow investors and traders who match your style.
Interact with a deep investing community.
Journal your ideas - the best investors do!

View profile on Twitter

MaverickNY

Join StockTwits Today!

Sign in to StockTwits X

New to StockTwits?

Sign up for real time news, charts, and ideas on the stocks you care about.